What would you do, doctor sahib ?: Pre-natal testing in the socio-cultural context of India by Gupta, J.A.
18 The Focus: Genomics in Asia The Focus: Genomics in Asia 19
‘What would you do, doctor sahib?’ Pre-natal testing in the socio-cultural context of India  
The Newsletter | No.52 | Winter 2009 The Newsletter | No.52 | Winter 2009
In urban India, there is an increasing public awareness regarding the role of genes in the incidence of 
disease and the possibility of making use of pre-natal testing (PNT). PNT is associated with modernity 
and good parenthood. In this paper, Jyotsna Agnihotri Gupta throws light on women’s use of PNT for 
pregnancy management and the decision making regarding genetic testing – and whether to continue 
the pregnancy following a ‘positive’ test result – in order to achieve the birth of ‘healthy’ children.
Jyotsna Agnihotri Gupta
GENETICISTS IN INDIA could be the new pundits instead 
of the ones traditionally casting horoscopes after the birth of 
a child to predict the future course of its life. Since the second 
half of the 20th century genetics is slowly changing cultural 
understandings of health and illness, introducing a new 
dimension to health care. Seventy percent of India’s approx-
imately 1.17 billion population lives in rural areas, where 
basic health care services are either unavailable or inadequate. 
India scores very low on important health indicators such 
as life expectancy, infant and child mortality and maternal 
mortality. Given the size of the country’s population, genetic 
diseases aff ect a small number of people, and when diagnosed, 
they are largely untreatable. However, for the families 
concerned they pose a considerable burden, since care and 
rehabilitation facilities for individuals with genetic disorders 
are very poor. 
Reproductive genetics
Over 25 million births occur annually in India. The infant and 
child mortality rate is very high, with infectious diseases being 
the primary cause of death. Most births still take place under the 
supervision of (skilled or unskilled) traditional birth attendants 
and there is a lack of simple ante-natal and post-natal services 
in rural areas. In the cities pre-natal check-ups of pregnancies 
occur in clinics and thus congenital malformations and genetic 
disorders may get diagnosed; they are increasingly reported 
as important causes of peri-natal mortality. If the incidence of 
birth defect is assumed to be two per cent, then 500,000 babies 
are born with some form of birth defect every year in India.1 
Paediatricians and geneticists argue that prevention is the best 
strategy, considering that cure after birth is diffi  cult and costly. 
With the proliferation of genetic tests, testing is becoming a part 
of ‘good parenthood’ at the individual level. At the societal level, 
community genetics is emerging as a practice and as a future 
model in which the options off ered by genetic testing techno-
logies can be used optimally for the realisation of preventive 
health care. Certain genetic conditions are seen as a major drain 
on the quality of life of the individuals concerned and their 
families, as well as on health resources. While the prevalence 
of haemoglobinopathies (blood-related diseases) , such as 
thalassaemia and sickle-cell disease and its variants has been 
noted in certain communities and regions of India, recent studies 
bear out that the primary reason for referral at genetic med-
icine departments is reproductive genetics. The main aim of 
reproductive genetics is early detection of a heightened risk of 
giving birth to children with a disorder which is untreatable and 
which could (in varying degrees) undermine the child's quality 
of life and life span, depending on the severity of the condition.
Genetic testing
Genetic testing may be carried out at diff erent times 
throughout life and through the use of various techniques. 
In general there are four moments of genetic testing: 
(1) carrier testing; (2) preconceptional testing of the embryo 
in assisted reproduction (IVF), referred to as pre-implantation 
genetic diagnosis (PGD); (3) pre-natal testing of the foetus 
during pregnancy (PNT); and (4) screening of neo-natals, 
or later in life for late onset genetic conditions. 
The most common form of genetic testing is pre-natal testing 
(PNT). PNT refers to all methods used to ascertain the health 
of the developing foetus. These include biochemical screening 
(maternal serum alpha-fetoprotein, triple marker screening), 
ultrasound, chorionic villi sampling2, amniocentesis3, fl uores-
cent in situ hybridisation technology (FISH), and DNA assays. 
Diff erent techniques may be used for PNT, either individually 
or in combination. Some tests are not in themselves diagnostic 
and serve only as a fi rst stage in screening for certain disorders; 
other tests, even using diff erent methods of diagnosis, may 
be required to come to more or less reliable results. Genetic 
tests are quite expensive and not all families can aff ord them.
Pre-natal genetic testing in India
Increasingly urban Indian women are undergoing PNT to 
produce ‘healthy’ children. During my empirical research in 
hospitals in Delhi and Mumbai in 2007 and 2008 I found that 
pregnant women registering with gynaecologists in cities 
were increasingly being advised to have a triple marker test 
in the fi rst trimester of pregnancy. A very large number of 
them received a ‘positive’ diagnosis, i.e. a heightened risk of 
the foetus being aff ected, and were advised to undergo further 
tests such as chorionic villi sampling or amniocentesis in the 
second trimester. Often, women seeking further testing and 
genetic counselling were those who had suff ered repeated 
miscarriages, or were ‘high-risk pregnancies’ due to advanced 
maternal age (cut-off  point used is 35 years). Also, there were 
pregnant women and couples with an elevated risk – with a 
family history of a genetic disorder, knowledge of an abnormal 
gene in the family, a previous child with a disorder, or suspect 
fi ndings from previous tests. However, on examination of the 
records of the cytogenetic laboratories of the two hospitals 
in Delhi where I conducted research, I discovered that in 
95 percent of the cases sent for second trimester testing it 
was a false alarm and no abnormality was detected. 
PNT plays upon two fundamental desires of all couples: 
to become parents and to produce healthy and ‘normal’ 
children. Pregnant women seemed to have ambivalent feelings 
regarding PNT. They were not suffi  ciently informed regarding 
genetic tests and procedures and what the diseases meant 
in terms of reduced functioning. The very existence of these 
technologies, coupled with the advice of their gynaecologists 
and/or genetic counsellors to undergo these tests, created 
a kind of pressure on women. As one woman put it ‘Is it 
necessary to go through this [amniocentesis]? No one in the 
family has a genetic condition.’ While they did not want to risk 
giving birth to a disabled child, many women mentioned that 
before the technology appeared women were giving birth 
to healthy babies, also at an advanced age. Yet, once advised 
testing, many saw it as a necessary evil and complained about 
the anxiety caused by the tests until the results were known, 
the inconclusiveness of certain tests entailing the need for 
further tests, and the concomitant risk of miscarriage. 
It is remarkable that none of the women/couples I interviewed 
said they would continue the pregnancy following a ‘positive’ 
test result. The ‘pressure’ to choose abortion after PNT was 
rather subtle: it arose mainly from intending parents’ own 
understanding that it was ‘not fair toward a child to bring it 
to birth with a severe disability’. The main reasons for the 
proliferation of PNT are the dearth of institutional facilities for 
the disabled, and absence of medical insurance to bear the 
costs of often very expensive therapies for a child who suff ers 
from a genetic condition. Caring for a disabled child results in 
an enormous fi nancial and care burden for families, the latter 
falls mainly on the women. Also, fear of social stigmatisation 
not only of the aff ected child, but its parents and the whole 
family plays an important role. For this reason genetic testing 
and genetic counselling are increasingly sought.
Genetic counselling
Clinical facilities for genetic investigation in India are rather 
poor and there is a shortage of trained clinical geneticists. 
There are only 25 genetic counselling centres in the whole 
country. According to geneticist I.C. Verma (personal 
communication):
“Much of the work consists of providing information – 
helping patients to come to a decision. Many come with 
some diagnosis already; we make a more specifi c diagnosis.
 It often comes as a real shock to them. They are not ready 
to accept that there is no treatment for the condition. 
They require a period of adjustment. There is no rejection 
of aff ected children once they are born. There is more 
acceptance here than in the West… They do express their 
diffi  culty in looking after an aff ected child. Having a child 
with a genetic disease is quite tough… Patients wonder 
‘why has it happened to us?’ Some put all their faith in 
the counsellor and listen to you; some check and recheck; 
they doubt everything you say. Some are angry at the doctor 
about what has happened. Financial reason is important. 
Family members’ views are very important. They discuss with 
their own parents; generally they don’t want to let other 
family members know, because of social stigma.” 
Although genetic counsellors uphold the principle of non-
directive counselling, i.e. let women/couples themselves decide 
regarding (further) testing and whether to continue the preg- 
nancy after an adverse test result, they say, that in general: 
“Parents want more directive advice. ‘What would you do, doctor 
sahib, in our situation?’ Non-directive advice is not acceptable, 
because they are not so literate about science. They say they 
will discuss with the family whether to go for further testing. 
Unlike the West, whenever there is an abnormality in a child the 
whole family comes for counselling here. It is very rare that only 
a couple comes; in fact the couple is the quietest… We try to 
take away the guilt of having given birth to an abnormal baby.” 
(Dr I.C. Verma)
In principle, genetic tests may be empowering for women who 
are the child bearers and carry the primary responsibility for 
raising children, and caring for the sick and elderly. However, 
there may also be negative consequences of PNT for pregnant 
women. In the highly patriarchal Indian society men and the 
woman’s marital family traditionally make important deci-
sions within the family. Women may face coercion in making 
reproductive choices regarding not only the number of children 
(quantity), but also the kind of children (quality) to be born, 
thus making it diffi  cult to ensure their free and informed 
consent for use of genetic services. Also, the consequences 
of a ‘positive’ test may be disastrous for a daughter-in-law, 
as women often feel guilty or are blamed for producing a girl, 
or a disabled child. There were cases when husbands refused 
to be tested for carrier status for thalassaemia, although they 
were informed that the future off spring may actually manifest 
the disease only if both the parents were carriers.
Enhancing informed decision making 
Prevention of serious disease through genetic testing is a 
legitimate public health goal. It is imperative that the govern-
ment invests in increasing health facilities for genetic testing in 
the public sector, so that for families at risk, if desired, genetic 
testing is aff ordable and accessible. Simple screening and 
diagnostic facilities at district health centres with the possibility 
of referral to specialised centres should be provided. Health 
literacy programmes for the public which include information 
on genetics and on societal implications of developments 
in the fi eld of human genetics need serious attention. 
Developments in genetic technology concern all individuals, 
but since it is women who bear children and are the main carers, 
decisions aff ecting their pregnancy and outcome concern them 
more. Introducing pre-natal testing as part of standard pre-natal 
care should go hand-in-hand with an adequate system of 
informing and counselling women about pre-natal screening 
to ensure informed decision-making. Research has shown that 
decision aids are able to improve the quality and the level of 
informedness of pre-natal testing decisions and such decision 
aids should be developed and implemented in the pre-natal 
testing setting. Education materials need to be developed on 
genetic testing and screening that are culturally sensitive and 
in an accessible language. Also, the government needs to invest 
in institutions and care facilities for the disabled, and support 
for families with disabled children so that pregnant women 
do not feel compelled that terminating the pregnancy of an 
aff ected foetus is the only possible choice.
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